Filing Details
- Accession Number:
- 0001061983-17-000064
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-11-03 20:27:08
- Reporting Period:
- 2017-11-01
- Accepted Time:
- 2017-11-03 20:27:08
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1061983 | Cytokinetics Inc | CYTK | Pharmaceutical Preparations (2834) | 943291317 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1551778 | Ibraham Fady Malik | 280 East Grand Avenue South San Francisco CA 94080 | Evp Research & Development | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2017-11-01 | 694 | $11.10 | 47,540 | No | 4 | M | Direct | |
Common Stock | Disposition | 2017-11-01 | 178 | $13.05 | 47,362 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2017-11-01 | 2,639 | $11.10 | 50,001 | No | 4 | M | Direct | |
Common Stock | Disposition | 2017-11-01 | 800 | $13.10 | 49,201 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2017-11-01 | 694 | $11.10 | 49,895 | No | 4 | M | Direct | |
Common Stock | Disposition | 2017-11-01 | 300 | $13.13 | 49,595 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2017-11-01 | 2,639 | $11.10 | 52,234 | No | 4 | M | Direct | |
Common Stock | Disposition | 2017-11-01 | 1,300 | $13.15 | 50,934 | No | 4 | S | Direct | |
Common Stock | Disposition | 2017-11-01 | 100 | $13.18 | 50,834 | No | 4 | S | Direct | |
Common Stock | Disposition | 2017-11-01 | 300 | $13.20 | 50,534 | No | 4 | S | Direct | |
Common Stock | Disposition | 2017-11-01 | 400 | $13.23 | 50,134 | No | 4 | S | Direct | |
Common Stock | Disposition | 2017-11-01 | 200 | $13.25 | 49,934 | No | 4 | S | Direct | |
Common Stock | Disposition | 2017-11-01 | 200 | $13.30 | 49,734 | No | 4 | S | Direct | |
Common Stock | Disposition | 2017-11-01 | 400 | $13.35 | 49,334 | No | 4 | S | Direct | |
Common Stock | Disposition | 2017-11-01 | 300 | $13.55 | 49,034 | No | 4 | S | Direct | |
Common Stock | Disposition | 2017-11-01 | 600 | $13.60 | 48,434 | No | 4 | S | Direct | |
Common Stock | Disposition | 2017-11-01 | 900 | $13.65 | 47,534 | No | 4 | S | Direct | |
Common Stock | Disposition | 2017-11-01 | 400 | $13.68 | 47,134 | No | 4 | S | Direct | |
Common Stock | Disposition | 2017-11-01 | 100 | $13.80 | 47,034 | No | 4 | S | Direct | |
Common Stock | Disposition | 2017-11-01 | 843 | $13.80 | 46,191 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Incentive Stock Option (right to buy) | Disposition | 2017-11-01 | 2,639 | $0.00 | 2,639 | $11.10 |
Common Stock | Incentive Stock Option (right to buy) | Disposition | 2017-11-01 | 2,639 | $0.00 | 2,639 | $11.10 |
Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2017-11-01 | 694 | $0.00 | 694 | $11.10 |
Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2017-11-01 | 694 | $0.00 | 694 | $11.10 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
2,639 | 2009-03-26 | 2019-02-26 | No | 4 | M | Direct |
0 | 2009-03-26 | 2019-02-26 | No | 4 | M | Direct |
694 | 2009-03-26 | 2019-02-26 | No | 4 | M | Direct |
0 | 2009-03-26 | 2019-02-26 | No | 4 | M | Direct |
Footnotes
- The exercise(s) reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29,2017.
- The sale(s) reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29, 2017.